DSM-5 Psychiatric/General Medical Interface Study Group

DSM-5 Psychiatric/General Medical Interface Study Group and  Somatic Symptom Disorders Work Group  

Post #19 Shortlink: http://wp.me/pKrrB-zC

On 10 February, when the American Psychiatric Association (APA) published draft proposals for DSM-5 categories, it launched new DSM-5 Development web pages. Links on this site posted prior to 10 February will link to the old APA DSM-V pages. This will be attended to as soon as possible.

This new DSM-5 Development website page Somatic Symptom Disorders Work Group links to biosketches and COI disclosure information for each Somatic Symptom Disorders Work Group member. Under the chairmanship of Joel E Dimsdale, MD, the nine Work Group members are:  

Somatic Symptom Disorders Work Group

Dimsdale, Joel E., M.D.
Barsky III, Arthur J., M.D. *
Creed, Francis, M.D. *
Frasure-Smith, Nancy, Ph.D.
Irwin, Michael R., M.D.
Keefe, Francis J., Ph.D.
Lee, Sing, M.D.
Levenson, James L., M.D. *
Sharpe, Michael, M.D . *
Wulsin, Lawson R., M.D. 

*Four members of the Somatic Symptom Disorders Work Group, Arthur Barsky, MD, Francis Creed, MD, James Levinson, MD and Michael Sharpe, MD, had been members of the Conceptual Issues in Somatoform and Similar Disorders (CISSD) Project workgroup.  Professor Michael Sharpe had served as the CISSD Project’s UK Chair.  

**The CISSD Project was an unofficial project undertaken between 2003 and 2007, initiated and co-ordinated by Dr Richard Sykes, PhD, former Director of Westcare UK (engulfed by Action for M.E. in mid 2002). Action for M.E. acted as Principal Administrators for the project. The Principal Collaborator was Professor Rachel Jenkins, WHO Collaborating Centre, Institute of Psychiatry, London.

The 2007 paper: Kroenke K: Somatoform disorders and recent diagnostic controversies. Psychiatr Clin North Am 2007 Dec;30(4):593-619. http://www.ncbi.nlm.nih.gov/pubmed/17938036

contains the caveat:

“Although the CISSD is an ad hoc group that includes many international experts on somatoform disorders, it was neither appointed nor sanctioned by the APA or WHO, the organizations authorized to approve revisions of DSM and ICD, respectively. As such, the CISSD recommendations should be considered advisory rather than official. Also, there were some suggestions for which the CISSD achieved near consensus but other issues where opinions diverged considerably.”

**The Dx Revision Watch pages for the CISSD Project are under construction. 

Study Groups 

According the APA:

“As development on DSM-5 progressed, the importance of addressing cross-cutting issues relevant to all of the disorder work groups became increasingly evident. As a result, six DSM-5 Study Groups were formed to address these universal topic areas.”

Psychiatric/General Medical Interface Study Group  

“The Psychiatric/General Medical Interface Study Group is chaired by Lawson R. Wulsin, M.D. The study group is examining the link between general medical disorders and psychiatric disorders. Given that most patients with mental illnesses are seen by primary care physicians, the study group aims to ensure that DSM-5 meets the needs of general medical practitioners and not just specialty mental health clinicians. The group is also developing revision strategies for the forthcoming DSM-5-PC, which is intended to be used in primary care settings. The members of the Psychiatric/General Medical Interface Study Group are listed below.” 

Psychiatric/General Medical Interface Study Group Members 

Wulsin, Lawson R., M.D. [Member, Somatic Symptoms Disorders Work Group]
Dahl, Ronald E., M.D.
Dimsdale, Joel E., M.D. [Chair, Somatic Symptoms Disorders Work Group]
Escobar, Javier I., M.D. [Member, DSM-5 Task Force and Liaison to SSD Work Group]
Jeste, Dilip V., M.D.
Kaufmann, Walter E., M.D.
Kreipe, Richard E., M.D.
Petersen, Ronald, Ph.D., M.D.
Reynolds, Charles F., M.D.
Segraves, Taylor R., M.D., Ph.D.
Walsh, Timothy B., M.D. 

Javier Escobar, MD, Director of the University of Medicine and Dentistry of New Jersey (UMDNJ) – Robert Wood Johnson Medical School (RWJMS) Medically Unexplained Physical Symptoms (MUPS) Research Center, which has been supported with over $4M in funding by the US National Institute of Mental Health (NIMH), had also been a member of the CISSD Project workgroup. 

Dr Escobar is a member of the DSM-5 Task Force, serves as Task Force liaison to the DSM-5 Somatic Symptom Disorders Work Group and according to the Task Force, works closely with this work group.  

DSM-5 Development Timeline

DSM-5 Development Timeline

Post #18 Shortlink: http://wp.me/pKrrB-zf

As part of the launch of its new DSM-5 Development webpages, the American Psychiatric Association (APA) has issued a more comprehensive Timeline:

[Timeline superceded by revised Timeline.]

APA publishes proposed revisions and draft criteria for DSM-5 categories

APA publishes proposed revisions and draft criteria for DSM-5 (DSM-V) categories

Post #16 Shortlink: http://wp.me/pKrrB-xG

Today, 10 February, the American Psychiatric Association (APA) released draft proposals for revisions to DSM-IV and draft criteria for DSM-5.

American Psychiatric Association DSM-5 Development

Proposed Draft Revisions to DSM Disorders and Criteria are published here on the APA’s relaunched DSM-5 website  

http://www.dsm5.org/Pages/Default.aspx

Selected material for revision of “Somatoform Disorders” on this DSM-5 Watch page

Draft proposals DSM-5

The comment period runs from 10 February to 20 April.

Open APA News Release here in PDF format: Diag Criteria General FINAL 2.05

or text below

http://www.dsm5.org/Newsroom/Documents/Diag%20%20Criteria%20General%20FINAL%202.05.pdf

APA News Release: 

Public release date: 10-Feb-2010

Contact: Jaime Valora
jvalora@psych.org
703-907-8562
American Psychiatric Association

APA announces draft diagnostic criteria for DSM-5

New proposed changes posted for leading manual of mental disorders

ARLINGTON, Va. (Feb. 10, 2010) – The American Psychiatric Association today released the proposed draft diagnostic criteria for the fifth edition of Diagnostic and Statistical Manual of Mental Disorders (DSM). The draft criteria represent content changes under consideration for DSM, which is the standard classification of mental disorders used by mental health and other health professionals, and is used for diagnostic and research purposes.

“These draft criteria represent a decade of work by the APA in reviewing and revising DSM,” said APA President Alan Schatzberg, M.D. “But it is important to note that DSM-5 is still very much a work in progress – and these proposed revisions are by no means final.” The proposed diagnostic criteria will be available for public comment until April 20, and will be reviewed and refined over the next two years. During this time, the APA will conduct three phases of field trials to test some of the proposed diagnostic criteria in real-world clinical settings.

Proposed revisions

Members of 13 work groups, representing different categories of psychiatric diagnoses, have reviewed a wide body of scientific research in the field and consulted with a number of expert advisors to arrive at their proposed revisions to DSM. Among the draft revisions are the following:

• The recommendation of new categories for learning disorders and a single diagnostic category, “autism spectrum disorders” that will incorporate the current diagnoses of autistic disorder, Asperger’s disorder, childhood disintegrative disorder and pervasive developmental disorder (not otherwise specified). Work group members have also recommended that the diagnostic term “mental retardation” be changed to “intellectual disability,” bringing the DSM criteria into alignment with terminology used by other disciplines.

• Eliminating the current categories substance abuse and dependence, replacing them with the new category “addiction and related disorders.” This will include substance use disorders, with each drug identified in its own category.

• Eliminating the category of dependence will better differentiate between the compulsive drug-seeking behavior of addiction and normal responses of tolerance and withdrawal that some patients experience when using prescribed medications that affect the central nervous system.

• Creating a new category of “behavioral addictions,” in which gambling will be the sole disorder. Internet addiction was considered for this category, but work group members decided there was insufficient research data to do so, so they recommended it be included in the manual’s appendix instead, with a goal of encouraging additional study.

• New suicide scales for adults and adolescents to help clinicians identify those individuals most at risk, with a goal of enhancing interventions across a broad range of mental disorders; the scales include research-based criteria such as impulsive behavior and heavy drinking in teens.

• Consideration of a new “risk syndromes” category, with information to help clinicians identify earlier stages of some serious mental disorders, such as neurocognitive disorder (dementia) and psychosis.

• A proposed new diagnostic category, temper dysregulation with dysphoria (TDD), within the Mood Disorders section of the manual. The new criteria are based on a decade of research on severe mood dysregulation, and may help clinicians better differentiate children with these symptoms from those with bipolar disorder or oppositional defiant disorder.

• New recognition of binge eating disorder and improved criteria for anorexia nervosa and bulimia nervosa, as well as recommended changes in the definitions of some eating disorders now described as beginning in infancy and childhood to emphasize that they may also develop in older individuals.

The APA has prepared detailed press releases on each of these topics, which are available on the DSM-5 Web site.

Dimensional Assessments

In addition to proposed changes to specific diagnostic criteria, the APA is proposing that “dimensional assessments” be added to diagnostic evaluations of mental disorders. These would permit clinicians to evaluate the severity of symptoms, as well as take into account “cross-cutting” symptoms that exist across a number of different diagnoses (such as insomnia or anxiety).

“We know that anxiety is often associated with depression, for example, but the current DSM doesn’t have a good system for capturing symptoms that don’t fit neatly into a single diagnosis, said David Kupfer, M.D., chair of the DSM-5 Task Force. “Dimensional assessments represent an important benefit for clinicians evaluating and treating patients with mental illness. It may help them better evaluate how a patient is improving with treatment, help them address symptoms that affect a patient’s quality of life and better assess patients whose symptoms may not yet be severe – leading to earlier effective treatment.”

Careful Consideration of Gender, Race and Ethnicity

The process for developing the proposed diagnostic criteria for DSM-5 has included careful consideration of how gender, race and ethnicity may affect the diagnosis of mental illness. The team has sought significant involvement of women, members of diverse racial and ethnic groups, and international researchers and clinicians. The APA also designated a specific study group to review and research these issues, and ensure they were taken into account in the development of diagnostic criteria.

The Gender and Cross-Cultural Study Group reviewed epidemiological data sets from the United States and other countries to determine if there were significant differences in incidence of mental illness among different subgroups (e.g., gender, race and ethnicity) that might indicate a bias in currently-used diagnostic criteria, including conducting meta-analyses (additional analyses combining data from different studies). Group members reviewed the literature from a broad range of international researchers who have explored issues of gender, ethnic and racial differences for specific diagnostic categories of mental illness. The study group also considered whether there was widespread cultural bias in criteria for specific diagnoses.

As a result of this process, the study group has tried to determine whether the diagnostic categories of mental illness in DSM need changes in order to be sensitive to the various ways in which gender, race and culture affect the expression of symptoms.

Public Review of Proposed Revisions

The resulting recommendations for revisions to the current DSM are being posted on the APA’s Web site for the manual, www.DSM5.org, for public review and written comment. These comments will be reviewed and considered by the relevant DSM-5 Work Groups.

“The process for developing DSM-5 continues to be deliberative, thoughtful and inclusive,” explained Dr. Kupfer. “It is our job to review and consider the significant advances that have been made in neuroscience and behavioral science over the past two decades. The APA is committed to developing a manual that is both based on the best science available and useful to clinicians and researchers.”

Overview of DSM-5 Development Process

The last edition of DSM was published in 1994. Beginning in 2000, during the initial phase of revising DSM, the APA engaged almost 400 international research investigators in 13 NIH supported conferences. In order to invite comments from the wider research, clinical and consumer communities, the APA launched a DSM-5 Prelude Web site in 2004 to garner questions, comments, and research findings during the revision process.

Starting in 2007, the DSM-5 Task Force and Work Groups, made up of over 160 world-renowned clinicians and researchers, were tasked with building on the previous seven years of scientific reviews, conducting additional focused reviews, and garnering input from a wide range of advisors as the basis for proposing draft criteria. In addition to the work groups in diagnostic categories, there were study groups assigned to review gender, age and cross-cultural issues.

Based on the upcoming comments to the draft criteria and findings of the field trials, the work groups will propose final revisions to the diagnostic criteria in 2012. The final draft of DSM-5 will be submitted to the APA’s Assembly and Board of Trustees for their review and approval. A release of the final, approved DSM-5 is expected in May 2013.

###
The American Psychiatric Association is a national medical specialty society whose physician members specialize in the diagnosis, treatment, prevention and research of mental illnesses, including substance use disorders. Visit the APA at www.psych.org  and www.healthyminds.org .

DSM-5 in the media and reminder

DSM-5 in the media and a reminder

Post #15 Shortlink: http://wp.me/pKrrB-xv

Draft proposals for the revision of DSM-IV diagnostic categories are scheduled for publication on 10 February with a comment period expected to be open until 20 April.

Information around proposed revisions and draft criteria for DSM-5 categories currently classified under “Somatoform Disorders” will be published on this DSM-5 and ICD-11 Watch page:

DSM-5 draft and comment process

Psychiatric Times  |  Steven A. King, MD, MS  | 07 February 2010

DSM-V and Pain

Dr King is in the private practice of pain medicine in New York and he is also clinical professor of psychiatry at the New York University School of Medicine. 

The Economist  Print edition  |  04 January 2010

Psychiatric diagnosis

That way, madness lies

A new manual for diagnosing diseases of the psyche is about to be unveiled

ON FEBRUARY 10th the world of psychiatry will be asked, metaphorically, to lie on the couch and answer questions about the state it thinks it is in. For that is the day the American Psychiatric Association (APA) plans to release a draft of the fifth version of its Diagnostic and Statistical Manual of Mental Disorders (DSM-V). Mental illness carrying the stigma that it does, and the brain being as little-understood as it is, revising the DSM is always a controversial undertaking. This time, however, some of the questions asked of the process are likely to be particularly probing…

Read on here

Psychiatric Times  |  03 February 2010

CAUTION! Who Should Be the DSM-V Diagnostician?

By H. Steven Moffic, MD

…Much has been written about DSM-V, especially in Psychiatric Times, including concerns about transparency, diagnostic criteria, timing, and the influence of Pharma. The developmental group is now entering the stage of inviting comments from psychiatrists at large. Up until now, I believe virtually nothing has been discussed about who should use it. If we gradually obtain neuroimaging and/or genetic markers to improve diagnosing, it would seem that the diagnostic process will become even more of a medical one, most suitable for psychiatrists…

Read full article here

Authorstream Slide Presentation  |  Dr. Atiqul Haq Mazumder Post Graduate Student Department of Psychiatry BSMMU, Dhaka

Upcoming Changes in DSM-V: Upcoming Changes in DSM-V A Critical Review

Includes transcript of PowerPoint slide text

ICD on YouTube: ICD-11 ICF ICD ICAMP January 2010

ICD on YouTube: ICD-11 ICF ICD ICAMP Face to Face meeting January 2010

Post #14 Shortlink Post: http://wp.me/pKrrB-x7

IWHOCD11 Channel   [6.59 mins]

ICD-11 ICF ICD ICAMP January 2010.mp4

Related information:

WHO iCAMP ICD-ICF Linkages Meeting, Geneva, 28–29 January 2010: New documents on ICD-11 Revision site

 

DSM-5 Draft Criteria Available for Public Comment through April 20

DSM-5 Draft Criteria Available for Public Comment through April 20

Post #13 Shortlink: http://wp.me/pKrrB-x2

Source: Student Doctor

The American Psychiatric Association is seeking your comments on proposed criteria for the fifth edition of Diagnostic and Statistical Manual of Mental Disorders (DSM), the standard classification of mental disorders used by mental health and other health professionals for diagnostic and research purposes.

Proposed DSM-5 draft criteria will be available for review and comment at http://www.DSM5.org from February 10 to April 20, 2010. Health professionals, mental health consumers and family members are invited to visit the site to review and comment on the draft criteria.

DSM-5 remains a work in progress: following the public comment period, the DSM-5 Task Force and Work Groups will spend two years reviewing and refining proposed criteria based on public comments and the results of field trials, which will be conducted in three phases to test some of the proposed diagnostic criteria in real-world clinical settings.

The release of the final DSM-5 is expected in May 2013.

For more information, visit http://www.DSM5.org